fbpx

CooperVision Names Steven Robins as President, Americas

CooperVision
CooperVision Steven Robins president Americas

CooperVision has appointed Steven Robins as President, Americas, effective immediately. He is a three-decade healthcare veteran, with several previous high-profile corporate leadership and consulting roles in the vision care industry.

Robins was most recently Managing Partner and Principal for New England Consulting Group, where he worked with a range of Fortune 500 organizations across the medical device, pharmaceutical, and OTC/vitamin sectors. Among these were strategic engagements with CooperVision, including the U.S. introduction of its MiSight® 1 day contact lens for myopia control.

He has also served as Chief Marketing Officer and President of North American Vision Care for Bausch + Lomb, General Manager of Johnson & Johnson’s Consumer Healthcare business in Canada, and Group Marketing Director for Pfizer Consumer Healthcare.

“Steven has been working with CooperVision for a number of years on strategic, priority projects including our MiSight® 1 day contact lenses. I am impressed with his strategic thinking as well as his passion for the industry and our customers. He is a charismatic, engaging leader who undoubtedly will drive positive impacts throughout our Americas business.”

Debbie Olive, Chief Commercial Officer, CooperVision

“Since my first foray into ocular health almost 20 years ago, I have known that there’s something special about this industry, shown by the way its professionals and products come together to make the world better for millions of people every day. There are big opportunities in vision care, and CooperVision is a clear leader in several. It’s a privilege to join the company that has its sights set on becoming an even greater part of people’s lives through remarkable innovations and partnerships,” said Robins.

Robins holds a Bachelor of Arts from Bates College and has participated in the Pfizer Global Leadership Program with Harvard University. He plans to relocate to Rochester, N.Y., a community that he called home for several years.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

References:

† Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

Forward-Looking Statements

This press release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 including, among others, statements regarding the potential impact of new management and CooperVision’s opportunities in the Americas region. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties.

Among the factors that could cause actual results and future actions to differ materially from those described in forward-looking statements are risks relating to challenges inherent in developing, manufacturing, launching, marketing, and selling new products; risks relating to research and development, regulatory requirements, clinical studies, sales, marketing, and distribution plans and capabilities; potential product performance and quality issues; intellectual property risks; competition; and other factors described in CooperCompanies’ Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in Cooper’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, as such Risk Factors may be updated in annual and quarterly filings. CooperCompanies cautions investors that forward-looking statements reflect the company’s analysis only on their stated date. CooperCompanies disclaims any intent to update them except as required by law.

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb

Bausch + Lomb Corporation announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA). The acquisition strengthens Bausch + Lomb’s expanding clinical-stage pipeline.

“We’re focused on finding treatments that address unmet needs or significantly improve upon the current standard of care. Glaucoma and geographic atrophy are two areas where we believe that dramatic improvement is possible. Whitecap Biosciences’ investigational medicines show real promise when it comes to slowing vision loss and perhaps even improving vision for patients with glaucoma, which would be a long-overdue breakthrough.”

Yehia Hashad, MD, chief medical officer and executive vice president, Research & Development, Bausch + Lomb

Whitecap Biosciences was founded in 2015 to develop novel therapies for ophthalmic diseases with a focus on glaucoma, GA and other serious eye diseases. The company successfully completed Phase 2 clinical trials for WB007, a highly potent alpha-2 adrenergic agonist, in glaucoma. Additional clinical trials are planned for both glaucoma and GA.

Glaucoma is a chronic, progressive neurodegenerative disease that occurs when excessive eye pressure or other causes lead to damage of the optic nerve. As one of the leading causes of preventable blindness, glaucoma affects about four million people in the United States, but if caught early, it is possible to help slow and potentially prevent vision loss.1-3 GA, also known as advanced dry age-related macular degeneration, affects approximately one million people in the U.S.4

“Glaucoma and geographic atrophy can cause severe vision loss, with many patients experiencing progressive deterioration,” said Scott Whitcup, MD, a founder and former chief executive officer, Whitecap Biosciences. “By joining a global leader like Bausch + Lomb, we hope Whitecap’s assets will be developed into effective treatments that improve visual outcomes for patients.”

References

  1. National Eye Institute. Glaucoma and Eye Pressure. Retrieved from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma/glaucoma-and-eye-pressure. Reviewed on Nov. 12, 2024.
  2. John Hopkins. Glaucoma. Retrieved from https://www.hopkinsmedicine.org/health/conditions-and-diseases/glaucoma. Reviewed on Nov. 12, 2024.
  3. Ehrlich JR, Burke-Conte Z, Wittenborn JS, et al. Prevalence of Glaucoma Among US Adults in 2022. JAMA Ophthalmol. 2024;142(11):1046–1053. doi:10.1001/jamaophthalmol.2024.3884
  4. Saundankar V, Borns M, Broderick K, et al. Annual prevalence of geographic atrophy and wet age-related macular degeneration among Medicare Advantage enrollees in a US health plan. J. of Managed Care & Specialty Pharmacy 31(1). doi.org/10.18553/jmcp.2025.31.1.88

© 2025 Bausch + Lomb.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Step Into Bold Style: The New Icon Lacoste Collection

Voila Optik Jan-Feb 2025 Marchon Lacoste L6056S_749

The oversized unisex acetate model (L6056S) from the New Icon Lacoste collection commands attention with its bold lines and refined details. The acetate frame features a striking double bridge on the front, delivering a daring aesthetic.

Transparent temples reveal a metal core adorned with Lacoste’s signature pattern, further elevated by a printed logo in elegant gold and silver tones.

Distributed by Marchon: www.marchon.com

About Marchon:

Working with leading brands to constantly push the envelope through distinct designs, innovative materials and clever constructions, Marchon Eyewear’s goal is to consistently design distinctive eyewear that offers accessible quality, style and value.

Marchon is proud of its diversified portfolio of brands, covering key demand segments in the premium end of the market.

Marchon Eyewear distributes its products through a global network of subsidiaries and distributors, serving over 80,000 accounts in more than 100 countries.

Whether helping people access quality care, supporting eye care providers in managing their practice, or partnering with local organizations to aid our communities, VSP Vision™ is there with a comprehensive portfolio of brands that keep health at the center of everything we do. As the first not-for-profit eye health company, care and compassion have led our growth for nearly 70 years. Today, our focus remains on helping those we serve bring their best vision to life.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

Childhood Myopia (part 2 of 4)

Close-up photograph of a smiling child holding a contact lens on the tip of their finger. Childhood myopia remedies include specialty contact lenses.

By Thomas Weissberger, RO

There are three key rules for childhood visual environment

  1. Children and young teens should spend at least two hours per day outdoors. While this can seem hard to achieve, it may be mostly achieved at school for primary school aged children, when this intervention is most crucial to prevent or delay myopia.
  2. Sun protection without excessive risk of sun exposure e.g. wearing hats, sunglasses, and seeking shade, are vital for eye health.
  3. Kids should be physically active for at least 60 minutes per day. This should be moderate to-vigorous level activity spent outdoors which is all the better for their visual development. For primary school aged children, this may be mostly achieved during break times.

As important as lifestyle management is, compliance is difficult to adhere to, and thus we need to look at corrective actions. First, let us look at the two main contact-lens based treatments.

Contact-lens based childhood myopia remedies

Orthokeratology: (ortho-k) is a non-surgical treatment method for ametropias, that involves using specially designed rigid gas permeable contact lenses to reshape the cornea. By reshaping the cornea, ortho-k lenses can temporarily correct the refractive error allowing patients to see clearly without the need for glasses or contact lenses during waking hours.

An infographic describing orthokeratology as one of the childhood myopia remedies. It shows three diagrams: "Before" with the focus behind the retina, "During" with the lens reshaping the cornea, and "After wearing" with the focus corrected on the retina. The text at the bottom explains that orthokeratology corrects the shape of the cornea by wearing lenses at bedtime. All of the text also appears in French.

Ortho-k lenses are worn overnight and removed in the morning, and the cornea retains its reshaped curvature throughout the day. The reshaping effect is believed to be achieved by redistributing the cornea’s epithelial and stromal cells, which causes a temporary change in the shape and thickness of the cornea. It is important to note that ortho-k is not a permanent solution and requires ongoing treatment to maintain the effect.

Atropine: Although the specific mechanism of atropine in myopia management is not fully understood, it is thought to inhibit scleral thinning or stretching, and hence eye growth. Low doses of atropine in 0.01%, 0.02%, and 0.05% concentrations have been found to be effective in slowing down myopic progression.

What childhood myopia remedies can opticians offer?

As Opticians, treatment options include specially designed contact lenses and spectacle lenses, as well as an innovative new idea based on contrast theory (currently only available in Japan).

Contact Lenses:

  • MiSight® contact lenses from Coopervision are daily disposable, soft CLs designed to control myopia progression in children ages 8 to 15 years.
  • MiSight® lenses are uniquely designed with concentric rings etched into the lens periphery. This design helps to focus light directly onto the retina and corrects the refractive error without causing the eye to grow longer.

Glasses: All the various treatments involve some type of concentric design in the lenses that create defocus effects on the peripheral retina without involving central vision.

The two largest developers/manufacturers of specialty lenses designed as childhood myopia remedies are Hoya and EssilorLuxottica. Each has developed their own lens design using slightly different technology. ZEISS also launched a new design in June, ZEISS MyoCare lenses.


The Practical Professor: Optical Solutions for the Real World

I am a second generation optician and have made all aspects of opticianry and optics my life. I have over 10 years of teaching experience as a former professor in the Dispensing Opticians’ program at Seneca College and at Georgian College. I was also responsible for
modernization of the optical curriculum.

I am a trainer and trainee (One never stops learning!), and I am available to share my knowledge and experience with today’s eye care professionals. As the owner of Special Eyes Optical Services, I am dedicated to supporting the optical industry. You can reach out to me at Tom@SpecialeyesOpticalServices.com.

Want to see more like this article? Subscribe to our FREE print magazines and e-newsletters!

SNOB Milano Celebrates Its First Ten Years: A Decade of Growth, Innovation, and Consistency in the Optical World

Snob Milano

SNOB Milano celebrates an important milestone: ten years of activity. A decade in which the brand has evolved without ever betraying its essence, securing a prominent position in the global eyewear market.

SNOB MILANO_LA PROF_SNV214C004Z__m
SNOB MILANO LA PROF

Tommaso Bossetti, designer and founder of SNOB Milano, reflects on the journey so far: “We’ve carved out a privileged niche for ourselves in the clip-on sector, creating a recognisable and well-defined identity in the optical market. It’s not just the number of units sold or the turnover that satisfies us, but especially the daily recognition we receive from our customers and colleagues. Today, whenever a new brand launches a product with a magnetic clip-on, the question opticians and customers ask themselves is: ‘How does it compare to SNOB?'”

The consistency with which SNOB Milano has followed its vision and evolution has been crucial. In an ever-changing industry, the company has successfully combined technical research with refined aesthetics, delivering innovations that have never betrayed the brand’s essence: “We are not a successful brand, nor a niche brand, nor one destined for mass distribution… we are a bit of all of these, but always with a coherent soul, capable of evolving without ever betraying itself” Bossetti continues.

SNOB MILANO_FIN_SNV198C004Z__m
SNOB MILANO FIN

The brand’s journey has been marked by continuous technical improvements, without ever compromising on refined aesthetic research. Among the most significant achievements is the exclusive partnership with ZEISS Sunlens, which immediately elevated the clip-on line to a new level. This innovation has redefined the functionality of sunglasses. “We created a new gesture, a ritual that quickly spread on social media, generating word-of-mouth that also reached younger and female audiences. Our clip-on has become a symbol of practicality and quality, not just an accessory, but a true innovation that has made prescription frames even more versatile”.

SNOB MILANO_SCIANTOSA_titaniumSNV218TC001Z__m
SNOB MILANO SCIANTOSA

To celebrate this important anniversary, SNOB Milano will present two new developments at Mido 2025, marking the brand’s entry into previously unexplored territories. A new line of sunglasses, consisting of eight acetate models, all entirely made in Italy with ZEISS Sunlens lenses, and a renewed version of the famous Dogui, which evolves without losing its original shape, representing the essence of the brand. “We’ve changed everything to change nothing. It’s a statement of intent: to evolve without compromising our stylistic recognisability”.

The designer continues: “This anniversary is not just a point of arrival, but above all a starting point. The next ten years will be another challenge, where we will continue to focus on quality, innovation, and excellence, always striving to stay true to our philosophy”.

SNOB MILANO_VELOCE_titanium_SNV220TC002Z__m
SNOB MILANO VELOCE

Finally, a special thank you to those who have made this journey possible: collaborators, partners, and especially the Sordelli family, whose support and expertise have enabled SNOB Milano to achieve these results. “A special thanks to the Sordelli family, who welcomed me ten years ago. Without them, none of this would have been possible.”

Click Here for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Bausch + Lomb

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Corporation announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA).

Read more
Close-up photograph of a smiling child holding a contact lens on the tip of their finger. Childhood myopia remedies include specialty contact lenses.

Childhood Myopia (part 2 of 4)

Learn about the key rules for childhood visual development, and childhood myopia remedies that involve both contact lenses and glasses.

Read more
Snob Milano

SNOB Milano Celebrates Its First Ten Years: A Decade of Growth, Innovation, and Consistency in the Optical World

With its tenth anniversary, SNOB Milano is preparing to look to the future with the same passion and determination that have characterized it since day one

Read more
JF Rey image janvier 2025

Discover the New Sunglasses Collection STAR ERA. MODERN ICONS by J.F. Rey

Times change, but icons remain, continuing to inspire and captivate. This vision guided the creation of J.F. Rey’s new sunglasses collection, where they have adapted the timeless glamour to modern influences to bring 17 bold, iconic, and unforgettable designs to life for both men and women.

Read more
Voila November-December 2024 OGI Eyewear Gotcha

OGI’s Gotcha with this Fresh and Eye-catching Style

If you seek a fresh spin on a studious style, we Gotcha. This metal frame features a round shape with a funky flattened top and geometric edges.

Read more
Bausch + Lomb

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Corporation announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA).

Read more
Close-up photograph of a smiling child holding a contact lens on the tip of their finger. Childhood myopia remedies include specialty contact lenses.

Childhood Myopia (part 2 of 4)

Learn about the key rules for childhood visual development, and childhood myopia remedies that involve both contact lenses and glasses.

Read more
Snob Milano

SNOB Milano Celebrates Its First Ten Years: A Decade of Growth, Innovation, and Consistency in the Optical World

With its tenth anniversary, SNOB Milano is preparing to look to the future with the same passion and determination that have characterized it since day one

Read more
JF Rey image janvier 2025

Discover the New Sunglasses Collection STAR ERA. MODERN ICONS by J.F. Rey

Times change, but icons remain, continuing to inspire and captivate. This vision guided the creation of J.F. Rey’s new sunglasses collection, where they have adapted the timeless glamour to modern influences to bring 17 bold, iconic, and unforgettable designs to life for both men and women.

Read more
Voila November-December 2024 OGI Eyewear Gotcha

OGI’s Gotcha with this Fresh and Eye-catching Style

If you seek a fresh spin on a studious style, we Gotcha. This metal frame features a round shape with a funky flattened top and geometric edges.

Read more
Bausch + Lomb

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Corporation announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA).

Read more
Close-up photograph of a smiling child holding a contact lens on the tip of their finger. Childhood myopia remedies include specialty contact lenses.

Childhood Myopia (part 2 of 4)

Learn about the key rules for childhood visual development, and childhood myopia remedies that involve both contact lenses and glasses.

Read more
Snob Milano

SNOB Milano Celebrates Its First Ten Years: A Decade of Growth, Innovation, and Consistency in the Optical World

With its tenth anniversary, SNOB Milano is preparing to look to the future with the same passion and determination that have characterized it since day one

Read more
JF Rey image janvier 2025

Discover the New Sunglasses Collection STAR ERA. MODERN ICONS by J.F. Rey

Times change, but icons remain, continuing to inspire and captivate. This vision guided the creation of J.F. Rey’s new sunglasses collection, where they have adapted the timeless glamour to modern influences to bring 17 bold, iconic, and unforgettable designs to life for both men and women.

Read more
Voila November-December 2024 OGI Eyewear Gotcha

OGI’s Gotcha with this Fresh and Eye-catching Style

If you seek a fresh spin on a studious style, we Gotcha. This metal frame features a round shape with a funky flattened top and geometric edges.

Read more
Bausch + Lomb

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Corporation announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA).

Read more
Close-up photograph of a smiling child holding a contact lens on the tip of their finger. Childhood myopia remedies include specialty contact lenses.

Childhood Myopia (part 2 of 4)

Learn about the key rules for childhood visual development, and childhood myopia remedies that involve both contact lenses and glasses.

Read more
Snob Milano

SNOB Milano Celebrates Its First Ten Years: A Decade of Growth, Innovation, and Consistency in the Optical World

With its tenth anniversary, SNOB Milano is preparing to look to the future with the same passion and determination that have characterized it since day one

Read more
JF Rey image janvier 2025

Discover the New Sunglasses Collection STAR ERA. MODERN ICONS by J.F. Rey

Times change, but icons remain, continuing to inspire and captivate. This vision guided the creation of J.F. Rey’s new sunglasses collection, where they have adapted the timeless glamour to modern influences to bring 17 bold, iconic, and unforgettable designs to life for both men and women.

Read more
Voila November-December 2024 OGI Eyewear Gotcha

OGI’s Gotcha with this Fresh and Eye-catching Style

If you seek a fresh spin on a studious style, we Gotcha. This metal frame features a round shape with a funky flattened top and geometric edges.

Read more